A major study has shown across six different cancers (neuroblastoma, Wilms tumor, medulloblastoma, osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma), survival at three years was strongly linked to tumor stage at diagnosis, with survival decreasing as stage increased.